Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Hypertension. 2015 Mar 9;65(5):1134–1140. doi: 10.1161/HYPERTENSIONAHA.114.04840

Table 1.

Participants characteristics stratified by daily exposure to biomass fuel use status.

Participant Characteristics Non-user of biomass fuel Daily users of biomass fuels p-
value
Sample size 495 509
Sociodemographics
  Age in years, mean (SD) 55.0 (12.3) 55.6 (12.4) 0.46
  Men, n (%) 255 (51.5) 230 (45.2) 0.05
  Rural site, n (%) 3.4 95.1 <0.001
  Lowest wealth tertile, n (%) 109 (22.0) 362 (71.7) <0.001
  <6 years of education, n (%) 61 (12.3) 325 (63.9) <0.001
Anthropometrics
  BMI in kg/m2, mean (SD) 27.9 (4.3) 25.2 (3.8) <0.001
  BMI ≥ 30 kg/m2, n (%) 130 (26.3) 57 (11.2) <0.001
  Waist circumference in cm, mean (SD) 92.9 (10.6) 84.6 (11.4) <0.001
  Height in cm, mean (SD) 157.1 (9.0) 155.3 (7.9) <0.001
Hypertension outcomes
  Prehypertension, n (%) 33 (7.6) 79 (18.1) <0.001
  Hypertension, n (%) 56 (12.9) 51 (11.7) 0.58
  Use of anti-hypertensive medications, n (%) 39 (7.9) 8 (1.6) <0.001
Lung function
  Post-bronchodilator FVC in L, mean (SD) 3.75 (1.06) 3.61 (1.02) 0.04
  % predicted FVC, mean (SD) 111.0 (15.8) 112.0 (17.3) 0.36
Factors that may modify blood pressure
  Tobacco smoking in pack-years, mean (SD) 0.93 (4.4) 0.30 (2.1) 0.004
  Alcohol abuse, n (%) 97 (19.6) 84 (16.5) 0.21
  Diabetes, n (%) 30 (6.3) 17 (3.5) 0.05
  Low physical activity, n (%) 395 (80.1) 379 (74.6) 0.04
  Depressive symptoms, n (%) 93 (18.6) 168 (33.1) <0.001
  Use of lipid-lowering medication, n (%) 16 (3.2) 0 <0.001
  Use of diabetes medication, n (%) 17 (3.4) 6 (1.2) 0.02